Search

Your search keyword '"Kamei, Shinji"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Kamei, Shinji" Remove constraint Author: "Kamei, Shinji"
171 results on '"Kamei, Shinji"'

Search Results

5. Comparison of clinical efficacy and safety of weekly glucagon‐like peptide‐1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel‐group, multicentre, open‐label trial (COMING study)

7. There is a Close Association Between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study

9. Temporal lobe epilepsy associated with GAD autoimmunity

11. Syndrome of inappropriate secretion of thyroid-stimulating hormone in a subject with galactorrhea and menstrual disorder and undergoing infertility treatment

14. Rationale, design and baseline characteristics of the effect of canagliflozin in patients with type 2 diabetes and microalbuminuria in the Japanese population: The CANPIONE study.

17. Novel Urinary Glycan Biomarkers Predict Cardiovascular Events in Patients With Type 2 Diabetes: A Multicenter Prospective Study With 5-Year Follow Up (U-CARE Study 2)

24. Administration of RAS Inhibitor before the Onset of Diabetic Nephropathy Counteracts the Adverse Effect of Chronic Hyperglycemia and Reduces the Augmentation of Urinary Albumin Excretion: A Retrospective Clinical Study

25. Onset of type 1 diabetes mellitus and heparin-induced thrombocytopenia in a patient with Basedow's disease and idiopathic thrombocytopenic purpura: Novel combination as autoimmune polyglandular syndrome

26. Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis

27. Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus

28. Switching from low-dose thiazide diuretics to sodium-glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension

29. Report on the activities of the chart review subcommittee at Kawasaki Medical School Hospital

30. Advanced breast cancer in a relatively young man with severe obesity and type 2 diabetes mellitus

31. Werner Syndrome and Diabetes Mellitus Accompanied by Adrenal Cortex Cancer

33. Inadequate Triglyceride Management Worsens the Durability of Dipeptidyl Peptidase-4 Inhibitor in Subjects with Type 2 Diabetes Mellitus

34. Dramatic mitigation of bone pain after phosphorus replacement therapy in a subject with FGF23-related hypophosphatemic osteomalacia

35. Human serum albumin: Possible cause of insulin autoimmune syndrome

36. Association of GA/HbA1c ratio and cognitive impairment in subjects with type 2 diabetes mellitus

37. Temporal lobe epilepsy associated with GAD autoimmunity

38. Strawberry milk-like blood in a subject with diabetic lipemia: dramatic change to transparent color after insulin therapy

39. Clinical effects of liraglutide are possibly influenced by hypertriglyceridemia and remaining pancreatic β-cell function in subjects with type 2 diabetes mellitus

40. Seven-year Observational Study on the Association between Glycemic Control and the New Onset of Macroangiopathy in Japanese Subjects with Type 2 Diabetes

43. Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)

44. Case of disseminated pyomyositis in poorly controlled type 2 diabetes mellitus with diabetic ketoacidosis

45. Switching from low‐dose thiazide diuretics to sodium–glucose cotransporter 2 inhibitor improves various metabolic parameters without affecting blood pressure in patients with type 2 diabetes and hypertension.

46. A Case of Growth Failure Following Allogeneic Bone Marrow Transplantation Successfully Treated by Replacement with Recombinant Growth Hormone

47. Influence of atherosclerosis‐related risk factors on serum high‐sensitivity C‐reactive protein levels in patients with type 2 diabetes: Comparison of their influence in obese and non‐obese patients

48. Anti-hypertensive azelnidipine preserves insulin signaling and glucose uptake against oxidative stress in 3T3-L1 adipocytes

49. Automatic Isolation of Bone Marrow Mononuclesr Cells Using Fenwal CS-3000 Plus Blood Cell Sparator

Catalog

Books, media, physical & digital resources